Replies to post #221457 on Biotech Values

[RockRat]

PTI: Up over 300% (not a typo) now. Data has many red flags. Final timepoint data not reported, baseline imbalances, dubious claims of dose response, an exceptionally poor performance by placebo group, etc. No borrow, but options near the strike are available, and I just sold a few calls.

Regards, RockRat